Revisiting comorbidities in gout: a cluster analysis
Pascal Richette1, Pierre Clerson2, Laure Périssin3
1Université Paris 7, UFR médicale, Assistance Publique-Hôpitaux de Paris, Hôpital Lariboisière, Fédération de Rhumatologie, Paris, Cedex 10, France.
Insights
Cluster analysis identified five distinct patient groups based on comorbidities in gout. These phenotypes may indicate different underlying disease processes, aiding personalized gout management.
Area of Science:
- Rheumatology
- Internal Medicine
- Epidemiology
Background:
- Gout is frequently associated with numerous comorbidities, complicating patient management.
- The relationship between gout and its comorbidities is complex and not fully understood.
- Identifying distinct patient subgroups based on comorbidities can improve understanding of gout's pathophysiology.
Purpose of the Study:
- To identify distinct clinical phenotypes of gout based on comorbid conditions using cluster analysis.
- To explore the heterogeneity within a large cohort of patients diagnosed with gout.
Main Methods:
- A cross-sectional multicentre study involving 2763 patients with gout.
- Cluster analysis was performed on variables and observations to identify homogeneous patient subgroups.
- Key comorbidities analyzed included hypertension, obesity, diabetes, dyslipidaemia, heart failure, coronary heart disease, renal failure, liver disorders, and cancer.
Main Results:
- Five distinct clusters of gout patients were identified based on their comorbidity profiles.
- Cluster C1 (12%) had isolated gout with few comorbidities.
- Cluster C2 (17%) featured obesity and hypertension; C3 (24%) had high rates of type 2 diabetes; C4 (28%) presented with dyslipidaemia; C5 (18%) showed high prevalence of cardiovascular disease and renal failure.
Conclusions:
- Cluster analysis successfully differentiated gout patients into five distinct phenotypes.
- These identified phenotypes may represent different pathophysiological pathways in gout.
- This phenotyping approach could inform more targeted treatment strategies for gout patients.
Objectives:
The reciprocal links between comorbidities and gout are complex. We used cluster analysis to attempt to identify different phenotypes on the basis of comorbidities in a large cohort of patients with gout.
Methods:
This was a cross-sectional multicentre study of 2763 gout patients conducted from November 2010 to May 2011. Cluster analysis was conducted separately for variables and for observations in patients, measuring proximity between variables and identifying homogeneous subgroups of patients. Variables used in both analyses were hypertension, obesity, diabetes, dyslipidaemia, heart failure, coronary heart disease, renal failure, liver disorders and cancer.
Results:
Comorbidities were common in this large cohort of patients with gout. Abdominal obesity, hypertension, metabolic syndrome and dyslipidaemia increased with gout duration, even after adjustment for age and sex. Five clusters (C1-C5) were found. Cluster C1 (n=332, 12%) consisted of patients with isolated gout and few comorbidities. In C2 (n=483, 17%), all patients were obese, with a high prevalence of hypertension. C3 (n=664, 24%) had the greatest proportion of patients with type 2 diabetes (75%). In C4 (n=782, 28%), almost all patients presented with dyslipidaemia (98%). Finally, C5 (n=502, 18%) consisted of almost all patients with a history of cardiovascular disease and renal failure, with a high rate of patients receiving diuretics.
Conclusions:
Cluster analysis of comorbidities in gout allowed us to identify five different clinical phenotypes, which may reflect different pathophysiological processes in gout.
Related Concept Videos
Genome-wide Association Studies-GWAS
GWAS does not require the identification of the target gene involved in...
Factors Affecting Illness
For instance, risk factors are connected to illness,...
Rheumatic Heart Disease II: Clinical Manifestations and Diagnostic Studies
Chronic Pancreatitis II: Collaborative Care
Assessment:
Urinary Tract Calculi II: Pathophysiology and Clinical Manifestations
Peripheral Arterial Disease II: Clinical Manifestations and Diagnostic Evaluation
